You will receive free and discreet shipping with every order. For further advice and support, head over to the website now , where you'll find a huge range of hair loss treatments, from chewable ...

Hims & Hers Health (NYSE: HIMS), a telehealth platform, experienced an 8% increase in its stock on Friday, May 30th, following the announcement of a 4% reduction in its workforce.

Hims & Hers is the newest darling disrupting the telemedicine space. While shares have jumped 157% over the last year, Wall Street analysts don't seem overly bullish on the stock. Despite ...

Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on manufacturing mass copies of the weight-loss drug Wegovy.

Get custom skin care, from just $29/mo at Hims. Get up to $800 off your first order of Wegovy with Hims and take a step towards your health goals today! Subject to availbaility. For full terms and ...

Hims & Hers Health, Inc. HIMS announced its agreement to acquire ZAVA, a digital health platform in Europe. The deal, which marks a significant step toward its global expansion, will likely expand ...

Hims & Hers expanding in Europe with the purchase of London-based digital health platform ZAVA. The acquisition gives the health and wellness site an increased reach in the U.K., and launches the ...

Hims & Hers Health will acquire ZAVA, which operates a popular digital health platform in Europe. Hims & Hers says it expects the deal to be accretive by 2026. See how Matt Maley is positioning ...

The move will rapidly expand Hims & Hers’ reach, which has a current base of 2.4 million U.S. customers. As the only digital health company with over a decade of operations across Germany ...

Hims & Hers Health, Inc is a telehealth platform offering tailored health and wellness services, showing significant stock volatility recently. HIMS experienced a dramatic rise from $24.11 to $68. ...